Regulation of glycogen synthase kinase-3β by products of lipid peroxidation in human neuroblastoma cells

被引:38
作者
Dozza, B
Smith, MA
Perry, G
Tabaton, M
Strocchi, P
机构
[1] Univ Bologna, Dept Pharmacol, I-40126 Bologna, Italy
[2] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
[3] Univ Genoa, Dept Neurol Sci & Vis, Genoa, Italy
关键词
AKT; extracellular signal-regulated kinase 1/2; signalling pathway; glycogen synthase kinase-3 beta; lipid peroxidation; neuroblastoma cells;
D O I
10.1111/j.1471-4159.2004.02413.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The potential role of 4-hydroxynonenal (HNE), a major product of membrane lipid peroxidation, in regulating glycogen synthase kinase-3beta (GSK3beta) activity was examined in human neuroblastoma IMR-32 cells. The inhibition of GSK3beta activity by HNE was observed by in vitro kinase assays with two substrates, the synthetic glycogen synthase peptide-2 and the human recombinant tau. GSK3beta activity is regulated by Ser9 (inhibitory) and Tyr216 (stimulatory) phosphorylation. By using specific activity-dependent phospho-antibodies, immunoblot analysis revealed that HNE induces an increase in phosphorylation of GSK3beta in Ser9, enhancing basal phosphatidylinositol 3-kinase (PI3K)/AKT and extracellular signal-regulated kinase 2 (ERK2) signalling pathways. Ser9-GSK3beta phosphorylation induced by HNE was abolished by treatment with LY294002 or U0126, two inhibitors of PI3K/AKT and ERK pathways, respectively. These experiments provide evidence for a crucial role of the PI3K/AKT and ERK2 pathways as intracellular targets of HNE that mediate the inhibition of GSK3beta activity in regulating cellular response to HNE in viable cells under conditions in which membrane lipid peroxidation occurs. These data support a key role for GSK3beta as a mediator of the signalling pathways activated by oxidative stress, and therefore it may be included among the redox-sensitive enzymes.
引用
收藏
页码:1224 / 1232
页数:9
相关论文
共 55 条
[1]   Glycogen synthase kinase-3: Properties, functions, and regulation [J].
Ali, A ;
Hoeflich, KP ;
Woodgett, JR .
CHEMICAL REVIEWS, 2001, 101 (08) :2527-2540
[2]   The renaissance of GSK3 [J].
Cohen, P ;
Frame, S .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (10) :769-776
[3]   INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY INSULIN-MEDIATED BY PROTEIN-KINASE-B [J].
CROSS, DAE ;
ALESSI, DR ;
COHEN, P ;
ANDJELKOVICH, M ;
HEMMINGS, BA .
NATURE, 1995, 378 (6559) :785-789
[4]   Syk is required for the activation of Akt survival pathway in B cells exposed to oxidative stress [J].
Ding, JY ;
Takano, T ;
Gao, SY ;
Han, WH ;
Noda, C ;
Yanagi, S ;
Yamamura, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (40) :30873-30877
[5]   Free radicals in the physiological control of cell function [J].
Dröge, W .
PHYSIOLOGICAL REVIEWS, 2002, 82 (01) :47-95
[6]   Regulation of neuronal survival by the serine-threonine protein kinase Akt [J].
Dudek, H ;
Datta, SR ;
Franke, TF ;
Birnbaum, MJ ;
Yao, RJ ;
Cooper, GM ;
Segal, RA ;
Kaplan, DR ;
Greenberg, ME .
SCIENCE, 1997, 275 (5300) :661-665
[7]   New insights into the control of MAP kinase pathways [J].
English, J ;
Pearson, G ;
Wilsbacher, J ;
Swantek, J ;
Karandikar, M ;
Xu, SC ;
Cobb, MH .
EXPERIMENTAL CELL RESEARCH, 1999, 253 (01) :255-270
[8]   Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration [J].
Ferrer, I ;
Barrachina, M ;
Puig, B .
ACTA NEUROPATHOLOGICA, 2002, 104 (06) :583-591
[9]  
Ferrer I, 2001, BRAIN PATHOL, V11, P144
[10]   GSK3 takes centre stage more than 20 years after its discovery [J].
Frame, S ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2001, 359 (01) :1-16